Advances in biosynthesis of peptide drugs: Technology and industrialization
Biotechnology Journal · 2024-01 · 19 (1)
DOI: 10.1002/biot.202300256 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biotechnology Journal, online erschienen am 14.11.2023. Verfasst von Jing Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai, Shandong, China. Hauptthemen laut MEDLINE: Industrial Development, Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 102 Literaturangaben. Gefördert von: The National Key Research and Development Program of China, Special Plan for Major Scientific and Technological Innovation in Qingdao West Coast, High tech industrialization special project in cooperation between Jilin Province and the Chinese Academy of Sciences.
Abstract (Originalsprache)
Peptide drugs are developed from endogenous or synthetic peptides with specific biological activities. They have advantages of strong target specificity, high efficacy and low toxicity, thus showing great promise in the treatment of many diseases such as cancer, infections, and diabetes. Although an increasing number of peptide drugs have entered market in recent years, the preparation of peptide drug substances is yet a bottleneck problem for their industrial production. Comparing to the chemical synthesis method, peptide biosynthesis has advantages of simple synthesis, low cost, and low contamination. Therefore, the biosynthesis technology of peptide drugs has been widely used for manufacturing. Herein, we reviewed the development of peptide drugs and recent advances in peptide biosynthesis technology, in order to shed a light to the prospect of industrial production of peptide drugs based on biosynthesis technology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai, Shandong, China.
- College of Pharmacy, Binzhou Medical University, Yantai, Shandong, China.
- Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
- State Key Laboratory of Optoelectronic Materials and Technologies, School of Physics, Sun Yat-Sen University, Guangzhou, China.
ORCID-Profile: Wenjun Li
Förderung
- The National Key Research and Development Program of China
- Special Plan for Major Scientific and Technological Innovation in Qingdao West Coast
- High tech industrialization special project in cooperation between Jilin Province and the Chinese Academy of Sciences
Zitieren
APA
Wang, J., Chen, L., Qin, S., Xie, M., Luo, S. Z., & Li, W. (2024). Advances in biosynthesis of peptide drugs: Technology and industrialization. Biotechnology Journal, 19(1). https://doi.org/10.1002/biot.202300256
Vancouver
Wang J, Chen L, Qin S, Xie M, Luo SZ, Li W. Advances in biosynthesis of peptide drugs: Technology and industrialization. Biotechnology Journal. 2024;19(1). doi:10.1002/biot.202300256
BibTeX
@article{Wang2024,
author = {Wang, Jing and Chen, Long and Qin, Song and Xie, Mingyuan and Luo, Shi-Zhong and Li, Wenjun},
title = {Advances in biosynthesis of peptide drugs: Technology and industrialization},
journal = {Biotechnology Journal},
year = {2024},
volume = {19},
number = {1},
doi = {10.1002/biot.202300256}
}
EUVIMED